How is AI Influencing Rare Disease Treatments? [David Fajgenbaum] - with Dr. Sanjay Juneja
AI is reshaping rare disease treatments by accelerating drug repurposing, identifying therapeutic opportunities, and unlocking actionable insights hidden in clinical data. Discover how innovative frameworks and technology platforms are helping healthcare leaders, diagnostic companies, and telehealth providers uncover new treatment pathways faster and more efficiently. Dr. Sanjay Juneja (https://sjunejamd.com/) speaks with Dr. David Fajgenbaum (https://www.linkedin.com/in/davidfajgenbaum) about the ethical imperative of using AI-driven drug repurposing to address underserved rare conditions and the growing potential to surface overlooked therapies. Gain practical insights on decision-making, data analysis, and scalable solutions that can impact patient care.
--------
1:37
How does an open source drug discovery platform empower clinicians? - with Dr. Sanjay Juneja
Unlock faster, smarter drug repurposing with open-source data that arms clinicians and researchers with actionable insights. This discussion explores how cutting-edge AI and knowledge graphs are transforming access to potential therapies by ranking 4,000 approved drugs against thousands of diseases - all in record time. Host Dr. Sanjay Juneja speaks with Dr. David Fajgenbaum, Co-founder of Every Cure, to reveal how their platform delivers 75 million computed drug-disease scores directly into the hands of healthcare providers worldwide. Learn how this approach accelerates clinical decision-making, supports evidence-based research, and breaks down barriers to innovative care strategies.
--------
2:31
How does AI Prediction Translate to Patient Care? [David Fajgenbaum] - with Dr. Sanjay Juneja
AI prediction is transforming patient care by accelerating how life-saving treatments are identified, repurposed, and delivered to those in need. Discover how cutting-edge data analysis can uncover overlooked therapies and drive faster clinical decisions that impact real-world outcomes. Dr. Sanjay Juneja interviews Dr. David Fajgenbaum, co-founder of Every Cure, to reveal actionable strategies for leveraging artificial intelligence in healthcare systems. Learn how AI-powered frameworks are optimizing treatment selection, guiding clinical workflows, and informing executive decisions across provider networks, telehealth, laboratories, and diagnostics.
--------
3:18
Can AI Find the Cures We've Overlooked for Decades? - with Dr. Sanjay Juneja [FULL PODCAST]
The idea that artificial intelligence can uncover life-saving treatments hidden in plain sight is no longer science fiction. In a healthcare system that often favors costly innovation over accessible solutions, using AI to repurpose existing drugs offers a path to faster, affordable breakthroughs. Join Dr. Sanjay Juneja and Dr. David Fajgenbaum, co-founder of Every Cure, as they reveal how AI is accelerating the identification of overlooked therapies for rare and complex diseases. Learn about the critical frameworks behind drug repurposing, how predictive models like Matrix are reshaping disease treatment, and why open-source collaboration could transform healthcare delivery. If you are a physician, healthcare executive, engineer, or healthcare IT leader, this discussion offers essential insights into the future of clinical decision-making.
--------
50:55
How Does Data Normalization Impact AI? - with Mika Newton
Accurate clinical insights depend on more than just throwing a large language model at a problem. Data normalization and structured medical concepts shape how AI delivers precision in healthcare coding, clinical decision support, and patient care. Mika Newton, CEO of xCures, and Rajiv Haravu unpack how proprietary medical content, editorial policies, and knowledge graphs provide essential context that LLMs alone cannot offer. Learn why healthcare organizations still rely on medical code sets for reimbursement, accurate ICD-10 coding, and decision-making workflows - and how AI-driven agents may soon accelerate ontology creation, dictionary migration, and terminology mapping. Discover actionable frameworks and expert perspectives on leveraging AI in clinical environments to minimize hallucinations, enhance accuracy, and maintain relevance in a rapidly evolving healthcare landscape.
AI and Healthcare—with Mika Newton and Dr. Sanjay Juneja is an engaging interview series featuring world-renowned leaders shaping the intersection of artificial intelligence and medicine. Discover how AI is transforming healthcare today, addressing real-world challenges and improving patient outcomes.
This series caters to anyone’s listening style with bite-sized, commute-friendly insights and full-length interviews. Join co-hosts Mika Newton, CEO of xCures, and Dr. Sanjay Juneja, a globally recognized oncologist and VP of Clinical AI at Tempus AI, as they explore cutting-edge innovations with industry pioneers.
Originally launched as the TARGET: Cancer Podcast in 2021, the series evolved after 75 episodes into a comprehensive platform for AI and healthcare conversations.
Ireland